COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,086 Articles (22,658 medRxiv, 8,428 bioRxiv)

Most recent first Previous |  Page 264: Articles 2631-2640  | Next

The Mortality Burden from COVID in Low-Income Settings: Evidence from Verbal Autopsies in India
Malani, A., Zhao, W.
10.1101/2024.01.02.24300728 — Posted: 2024-01-03
Disentangling the relationship between cancer mortality and COVID-19
Hansen, C. L., Viboud, C., Simonsen, L.
10.1101/2024.01.02.24300715 — Posted: 2024-01-03
Antigen non-specific CD8+ T cells accelerate cognitive decline in aged mice following respiratory coronavirus infection
Reagin, K. L., Lee, R.-L., Cocciolone, L., Funk, K. E.
10.1101/2024.01.02.573675 — Posted: 2024-01-03
BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
Iqbal, N. T., Ahmed, K., Sattar, T., Aziz, F., Hussain, R.
10.1101/2024.01.02.573408 — Posted: 2024-01-03
Four Years of COVID-19: Saudi Arabia, Egypt and Pakistan Have the Highest Research Growth Rates From 2020-2023
Hassan, W., Zafar, M.
10.1101/2023.12.31.573759 — Posted: 2024-01-02
Metformin mitigates insulin signaling variations induced by COVID-19 vaccine boosters in type 2 diabetes
Zhai, L., ZHUANG, M., Wong, H. K., Lin, C., Zhang, J., Bao, G., ZHANG, Y., Xu, S., Luo, J., Yuan, S., Wong, H. L. X., Bian, Z.-X.
10.1101/2023.12.27.23299358 — Posted: 2024-01-02
Major role of S-glycoprotein in providing immunogenicity and protective immunity in mRNA lipid nanoparticle vaccines based on SARS-CoV-2 structural proteins
Bykonia, E. N., Kleymenov, D. A., Gushchin, V. A., Sinyavin, A. E., Mazunina, E. P., Kuznetsova, N., Kozlova, S. R., Zolotar, A. N., Shidlovskaya, E. V., Usachev, E. V., Pochtovyi, A. A., Kustova, D. D., Ivanov, I. A., Dmitriev, S. E., Ivanov, R. A., Logunov, D. Y., Gintsburg, A. L.
10.1101/2023.12.30.573713 — Posted: 2024-01-02
DNA origami vaccine (DoriVac) nanoparticles improve both humoral and cellular immune responses to infectious diseases
Zeng, Y., Young, O., Si, L., Ku, M. W., Isinelli, G., Rajwar, A., Jiang, A., Wintersinger, C., Graveline, A., Vernet, A., Sanchez, M., Ryu, J. H., Kwon, I. C., Goyal, G., Ingber, D., Shih, W.
10.1101/2023.12.29.573647 — Posted: 2024-01-02
Association between Cardiovascular Disease Risk and long COVID-19: A Systematic Review and Meta-analysis
Huang, Y., Wen, Z., Luo, H., Liao, Y., Chen, Z.
10.1101/2023.12.30.23300656 — Posted: 2023-12-31
Association of Obstructive Sleep Apnea with Post-Acute Sequelae of SARS-CoV-2 infection (PASC)
Quan, S. F., Weaver, M. D., Czeisler, M. E., Barger, L. K., Booker, L. A., Howard, M. E., Jackson, M. L., Lane, R. I., McDonald, C. F., Ridgers, A., Robbins, R., Varma, P., Wiley, J. F., Rajaratnam, S., Czeisler, C. A.
10.1101/2023.12.30.23300666 — Posted: 2023-12-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).